433 related articles for article (PubMed ID: 31164169)
1. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M
EClinicalMedicine; 2021 Aug; 38():101005. PubMed ID: 34308314
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
[TBL] [Abstract][Full Text] [Related]
4. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
[TBL] [Abstract][Full Text] [Related]
5. Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N
BMC Psychiatry; 2016 Dec; 16(1):428. PubMed ID: 27905916
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
Ahmadi J; Sahraian A; Biuseh M
Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
[TBL] [Abstract][Full Text] [Related]
7. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Ahmadi J; Razeghian Jahromi L
Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
[TBL] [Abstract][Full Text] [Related]
8. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
[TBL] [Abstract][Full Text] [Related]
9. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
[TBL] [Abstract][Full Text] [Related]
10. Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial.
Farahzadi MH; Moazen-Zadeh E; Razaghi E; Zarrindast MR; Bidaki R; Akhondzadeh S
J Psychopharmacol; 2019 Mar; 33(3):305-315. PubMed ID: 30526230
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
13. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
Cotton SM; Berk M; Watson A; Wood S; Allott K; Bartholomeusz CF; Bortolasci CC; Walder K; O'Donoghue B; Dean OM; Chanen A; Amminger GP; McGorry PD; Burnside A; Uren J; Ratheesh A; Dodd S
Trials; 2019 Nov; 20(1):658. PubMed ID: 31779696
[TBL] [Abstract][Full Text] [Related]
14. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.
Rossell SL; Francis PS; Galletly C; Harris A; Siskind D; Berk M; Bozaoglu K; Dark F; Dean O; Liu D; Meyer D; Neill E; Phillipou A; Sarris J; Castle DJ
BMC Psychiatry; 2016 Sep; 16(1):320. PubMed ID: 27629871
[TBL] [Abstract][Full Text] [Related]
16. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
[TBL] [Abstract][Full Text] [Related]
17. Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
Kotajima-Murakami H; Takano A; Ogai Y; Tsukamoto S; Murakami M; Funada D; Tanibuchi Y; Tachimori H; Maruo K; Sasaki T; Matsumoto T; Ikeda K
Neuropsychopharmacol Rep; 2019 Jun; 39(2):90-99. PubMed ID: 30756527
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence.
Grant JE; Odlaug BL; Kim SW
Eur Neuropsychopharmacol; 2010 Nov; 20(11):823-8. PubMed ID: 20655182
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
[TBL] [Abstract][Full Text] [Related]
20. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
De La Garza R; Mahoney JJ; Culbertson C; Shoptaw S; Newton TF
Pharmacol Biochem Behav; 2008 Apr; 89(2):200-8. PubMed ID: 18207225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
